Medicinal Plant-derived Nutraceuticals in Breast Cancer Therapy: Molecular Mechanisms and Clinical Prospects

Breast cancer today is still a leading cause of cancer-related mortality and morbidity around the world, which calls for supplementary and more convenient therapies. Nutraceuticals derived from medical plants have now emerged as promising candidates because they work through multiple mechanisms of action at the cellular level and can be combined with conventional treatments without the high level of accompanying toxicity. Research examines the molecular mechanisms by which leading phytochemicals such as curcumin, withaferin A, Epigallocatechin Gallate (EGCG) and glycosylates exert anti-cancer effects - including induction of apoptosis induction, cell cycle arrest, metastasis from one cell to another; hormone modulation and activation or precursor treatment in immune system cells. Possible adverse effects of these nutraceuticals along with some clinical findings to support their use as adjuvant agents aimed at reducing side effects of treatment and improving patient quality of life is discussed, together with current problems such as poor absorption rates in the human body, lack of internationally standardised chemical composition and regulatory barriers. The outlook is for advanced delivery systems; thorough clinical trials; personalised solutions tailored to individual patients� needs; and training programmes that give doctors and patients better knowledge of the topic. Well-established, scientifically validated nutraceuticals, used to treat breast cancer, have great potential for bringing a new generation of therapies and improving patients� overall health. Major Findings: Medicinal plant-derived nutraceuticals like curcumin, EGCG, and withaferin A show strong anti-breast cancer effects via multiple mechanisms. Despite promising preclinical results, clinical translation is limited by poor bioavailability and lack of large-scale trials, though these compounds may enhance current therapies if delivery and research gaps are addressed.

View article page

Download PDF